Clover Health INVESTMENTS, Corp. (CLOV) intrinsic value & 10-year financials
Clover Health INVESTMENTS, Corp. (CLOV) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 26.8% a year to $1.9B, with an average return on invested capital of -101.3%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $4.48
- Market cap
- $2.3B
- Revenue (FY2025)
- $1.9B
- Revenue growth (8-yr CAGR)
- 26.8%
- ROIC (10-yr avg)
- -101.3%
- Free cash flow (FY2025)
- -$69.0M
CLOV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.9B | -$85.5M | — | -$69.0M | -4.4% | -26.3% |
| FY2024 | $1.4B | -$43.0M | — | $33.3M | -3.3% | -27.5% |
| FY2023 | $2.0B | -$213.4M | -$0.44 | -$116.5M | -10.3% | -100.6% |
| FY2022 | $3.5B | -$338.8M | -$0.71 | -$208.4M | -10.7% | -146.0% |
| FY2021 | $1.5B | -$587.8M | -$1.42 | -$283.0M | -43.3% | -523.1% |
| FY2020 | $672.9M | -$6.7M | -$1.54 | -$2.9M | -1.0% | 41.2% |
| FY2019 | $462.3M | -$363.7M | -$4.14 | -$159.9M | -39.6% | 72.9% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CLOVER HEALTH INVESTMENTS, CORP. /DE revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
CLOVER HEALTH INVESTMENTS, CORP. /DE has historically struggled to out-earn its cost of capital, averaging just -47.6% ROIC.
CLOVER HEALTH INVESTMENTS, CORP. /DE capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CLOVER HEALTH INVESTMENTS, CORP. /DE is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-5.55 per share.